Molecular Classification to Prognosticate Response in Medically Managed Endometrial Cancers and Endometrial Intraepithelial Neoplasia
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular Classification to Prognosticate Response in Medically Managed Endometrial Cancers and Endometrial Intraepithelial Neoplasia
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 11, Pages 2847
Publisher
MDPI AG
Online
2021-06-08
DOI
10.3390/cancers13112847
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical features of ProMisE groups identify different phenotypes of patients with endometrial cancer
- (2021) Antonio Raffone et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Mismatch repair-deficiency specifically predicts recurrence of atypical endometrial hyperplasia and early endometrial carcinoma after conservative treatment: A multi-center study
- (2021) Antonio Raffone et al. GYNECOLOGIC ONCOLOGY
- Histopathological characterization of ProMisE molecular groups of endometrial cancer
- (2020) Antonio Raffone et al. GYNECOLOGIC ONCOLOGY
- Diagnostic accuracy of p53 immunohistochemistry as surrogate of TP53 sequencing in endometrial cancer
- (2020) Antonio Raffone et al. PATHOLOGY RESEARCH AND PRACTICE
- Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer
- (2020) Shannon N. Westin et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Mismatch repair status influences response to fertility-sparing treatment of endometrial cancer
- (2020) Young Shin Chung et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Clinical Predictive Factors of Response to Treatment in Patients Undergoing Conservative Management of Atypical Endometrial Hyperplasia and Early Endometrial Cancer
- (2020) Antonio Raffone et al. Journal of Adolescent and Young Adult Oncology
- Predictive Accuracy of Progesterone Receptor B in Young Women with Atypical Endometrial Hyperplasia and Early Endometrial Cancer Treated with Hysteroscopic Resection plus LNG-IUD Insertion
- (2020) Antonio Raffone et al. Journal of Minimally Invasive Gynecology
- Molecular classification defines outcomes and opportunities in young women with endometrial carcinoma
- (2019) Heidi Britton et al. GYNECOLOGIC ONCOLOGY
- Immunohistochemical predictive markers of response to conservative treatment of endometrial hyperplasia and early endometrial cancer: A systematic review
- (2019) Antonio Travaglino et al. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
- Application of the Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) to patients conservatively treated: Outcomes from an institutional series
- (2019) Francesca Falcone et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- TCGA molecular groups of endometrial cancer: Pooled data about prognosis
- (2019) Antonio Raffone et al. GYNECOLOGIC ONCOLOGY
- p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies
- (2019) Naveena Singh et al. JOURNAL OF PATHOLOGY
- Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series
- (2018) S Kommoss et al. ANNALS OF ONCOLOGY
- An NRG Oncology/GOG study of molecular classification for risk prediction in endometrioid endometrial cancer
- (2018) Casey M. Cosgrove et al. GYNECOLOGIC ONCOLOGY
- Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts
- (2016) Ellen Stelloo et al. CLINICAL CANCER RESEARCH
- Molecular classification of endometrial carcinoma on diagnostic specimens is highly concordant with final hysterectomy: Earlier prognostic information to guide treatment
- (2016) Aline Talhouk et al. GYNECOLOGIC ONCOLOGY
- Levonorgestrel-releasing intrauterine system vs oral progestins for non-atypical endometrial hyperplasia: a systematic review and metaanalysis of randomized trials
- (2015) Hatem Abu Hashim et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- A clinically applicable molecular-based classification for endometrial cancers
- (2015) A Talhouk et al. BRITISH JOURNAL OF CANCER
- Prognostic factors of oncological and reproductive outcomes in fertility-sparing treatment of complex atypical hyperplasia and low-grade endometrial cancer using oral progestin in Chinese patients
- (2015) Rong Zhou et al. GYNECOLOGIC ONCOLOGY
- Prognostic factors of regression and relapse of complex atypical hyperplasia and well-differentiated endometrioid carcinoma with conservative treatment
- (2015) Yu-Feng Yang et al. GYNECOLOGIC ONCOLOGY
- Fertility-Sparing Treatment of Early Endometrial Cancer and Complex Atypical Hyperplasia in Young Women of Childbearing Potential
- (2015) Stanislav Mikhailovich Pronin et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Oncologic and reproductive outcomes after fertility-sparing management with oral progestin for women with complex endometrial hyperplasia and endometrial cancer
- (2015) Ming Chen et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- Committee Opinion No. 631
- (2015) Vinita Parkash et al. OBSTETRICS AND GYNECOLOGY
- Prognostic factors of oncologic and reproductive outcomes in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma: systematic review and meta-analysis
- (2014) Martin Koskas et al. FERTILITY AND STERILITY
- Impact of obesity on the results of fertility-sparing management for atypical hyperplasia and grade 1 endometrial cancer
- (2014) Clémentine Gonthier et al. GYNECOLOGIC ONCOLOGY
- Combined medroxyprogesterone acetate/levonorgestrel–intrauterine system treatment in young women with early-stage endometrial cancer
- (2013) Mi Kyoung Kim et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Levonorgestrel-impregnated intrauterine device as treatment for endometrial hyperplasia: a national multicentre randomised trial
- (2013) A Ørbo et al. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
- LNG-IUS versus oral progestogen treatment for endometrial hyperplasia: a long-term comparative cohort study
- (2013) I. D. Gallos et al. HUMAN REPRODUCTION
- Integrated genomic characterization of endometrial carcinoma
- (2013) Gad Getz et al. NATURE
- Clinical Outcome of Atypical Endometrial Hyperplasia Diagnosed on an Endometrial Biopsy
- (2012) Emad Rakha et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002)
- (2012) Jeong-Yeol Park et al. EUROPEAN JOURNAL OF CANCER
- Absolute Risk of Endometrial Carcinoma During 20-Year Follow-Up Among Women With Endometrial Hyperplasia
- (2010) James V. Lacey et al. JOURNAL OF CLINICAL ONCOLOGY
- The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia—A long-term follow-up study
- (2008) Rajesh Varma et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now